Benztropine Mesylate Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis
Benztropine is used to treat symptoms of Parkinson's disease or involuntary movements due to the side effects of certain psychiatric drugs (antipsychotics such as chlorpromazine/haloperidol). Benztropine belongs to a class of medication called anticholinergics that work by blocking a certain neurotransmitters (acetylcholine). This helps decrease muscle stiffness, sweating, and the production of saliva, and helps improve walking ability in people with Parkinson's disease.
MARKET DYNAMICS
Benztropine mesylate market is driving due to factors such as growth in ageing population and the associated increase in the prevalence of Parkinson's disease, government funding for research. However, availability of alternative treatments and stringent regulations are likely to create a negative impact on the growth of this market.
MARKET SCOPE
The Benztropine mesylate market analysis to 2028 is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Benztropine mesylate Market with detailed market segmentation by route of administration and application. The Benztropine mesylate Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Benztropine mesylate market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The Benztropine mesylate market is segmented based on route of administration and application. Based on route of administration, market is segmented as oral, injection. Based on application, market is segmented as parkinsonism, extrapyramidal symptoms.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Benztropine mesylate market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Benztropine mesylate market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Benztropine mesylate market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Benztropine mesylate market in these regions.
![World Geography](https://www.theinsightpartners.com/assets/rdimages/world-geography.png)
Have a question?
![Analyst](https://www.theinsightpartners.com/assets/mrinal_kerhalkar.jpg)
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
![Analyst](https://www.theinsightpartners.com/assets/images/speak_analyst.gif)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Benztropine mesylate market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Benztropine mesylate market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Benztropine mesylate market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Benztropine mesylate market in these regions.
MARKET PLAYERS
The report covers key developments in the Benztropine mesylate market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as Application and End user launches, Application and End user approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Benztropine mesylate market are anticipated to have lucrative growth opportunities in the future with the rising demand for Benztropine mesylate in the global market. Below mentioned is the list of few companies engaged in the Benztropine mesylate Market.
The report also includes the profiles of key players in Benztropine mesylate market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Akorn
- Zydus Pharmaceuticals
- ANI Pharmaceuticals
- PLIVA
- Fresenius Kabi
- Hikma Pharmaceuticals
- Cipla
- Navinta
- Aspen Pharmacare
- Hospira Inc.
- LGM Pharma
- SG Pharma
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
![Report Coverage](https://www.theinsightpartners.com/assets/rdimages/report_coverage.png)
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
![Segment Covered](https://www.theinsightpartners.com/assets/rdimages/segment_covered.png)
Segment Covered
This text is related
to segments covered.
![Regional Scope](https://www.theinsightpartners.com/assets/rdimages/regional_scope.png)
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
![Country Scope](https://www.theinsightpartners.com/assets/rdimages/country_scope.png)
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Benztropine Mesylate Market - By Route of Administration
1.3.2 Benztropine Mesylate Market - By Application
1.3.3 Benztropine Mesylate Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. BENZTROPINE MESYLATE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. BENZTROPINE MESYLATE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. BENZTROPINE MESYLATE MARKET - GLOBAL MARKET ANALYSIS
6.1. BENZTROPINE MESYLATE - GLOBAL MARKET OVERVIEW
6.2. BENZTROPINE MESYLATE - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. BENZTROPINE MESYLATE MARKET - REVENUE AND FORECASTS TO 2028 - ROUTE OF ADMINISTRATION
7.1. OVERVIEW
7.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
7.3. ORAL
7.3.1. Overview
7.3.2. Oral Market Forecast and Analysis
7.4. INJECTION
7.4.1. Overview
7.4.2. Injection Market Forecast and Analysis
8. BENZTROPINE MESYLATE MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. PARKINSONISM
8.3.1. Overview
8.3.2. Parkinsonism Market Forecast and Analysis
8.4. EXTRAPYRAMIDAL SYMPTOMS
8.4.1. Overview
8.4.2. Extrapyramidal Symptoms Market Forecast and Analysis
9. BENZTROPINE MESYLATE MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Benztropine Mesylate Market Overview
9.1.2 North America Benztropine Mesylate Market Forecasts and Analysis
9.1.3 North America Benztropine Mesylate Market Forecasts and Analysis - By Route of Administration
9.1.4 North America Benztropine Mesylate Market Forecasts and Analysis - By Application
9.1.5 North America Benztropine Mesylate Market Forecasts and Analysis - By Countries
9.1.5.1 United States Benztropine Mesylate Market
9.1.5.1.1 United States Benztropine Mesylate Market by Route of Administration
9.1.5.1.2 United States Benztropine Mesylate Market by Application
9.1.5.2 Canada Benztropine Mesylate Market
9.1.5.2.1 Canada Benztropine Mesylate Market by Route of Administration
9.1.5.2.2 Canada Benztropine Mesylate Market by Application
9.1.5.3 Mexico Benztropine Mesylate Market
9.1.5.3.1 Mexico Benztropine Mesylate Market by Route of Administration
9.1.5.3.2 Mexico Benztropine Mesylate Market by Application
9.2. EUROPE
9.2.1 Europe Benztropine Mesylate Market Overview
9.2.2 Europe Benztropine Mesylate Market Forecasts and Analysis
9.2.3 Europe Benztropine Mesylate Market Forecasts and Analysis - By Route of Administration
9.2.4 Europe Benztropine Mesylate Market Forecasts and Analysis - By Application
9.2.5 Europe Benztropine Mesylate Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Benztropine Mesylate Market
9.2.5.1.1 Germany Benztropine Mesylate Market by Route of Administration
9.2.5.1.2 Germany Benztropine Mesylate Market by Application
9.2.5.2 France Benztropine Mesylate Market
9.2.5.2.1 France Benztropine Mesylate Market by Route of Administration
9.2.5.2.2 France Benztropine Mesylate Market by Application
9.2.5.3 Italy Benztropine Mesylate Market
9.2.5.3.1 Italy Benztropine Mesylate Market by Route of Administration
9.2.5.3.2 Italy Benztropine Mesylate Market by Application
9.2.5.4 Spain Benztropine Mesylate Market
9.2.5.4.1 Spain Benztropine Mesylate Market by Route of Administration
9.2.5.4.2 Spain Benztropine Mesylate Market by Application
9.2.5.5 United Kingdom Benztropine Mesylate Market
9.2.5.5.1 United Kingdom Benztropine Mesylate Market by Route of Administration
9.2.5.5.2 United Kingdom Benztropine Mesylate Market by Application
9.2.5.6 Rest of Europe Benztropine Mesylate Market
9.2.5.6.1 Rest of Europe Benztropine Mesylate Market by Route of Administration
9.2.5.6.2 Rest of Europe Benztropine Mesylate Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Benztropine Mesylate Market Overview
9.3.2 Asia-Pacific Benztropine Mesylate Market Forecasts and Analysis
9.3.3 Asia-Pacific Benztropine Mesylate Market Forecasts and Analysis - By Route of Administration
9.3.4 Asia-Pacific Benztropine Mesylate Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Benztropine Mesylate Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Benztropine Mesylate Market
9.3.5.1.1 Australia Benztropine Mesylate Market by Route of Administration
9.3.5.1.2 Australia Benztropine Mesylate Market by Application
9.3.5.2 China Benztropine Mesylate Market
9.3.5.2.1 China Benztropine Mesylate Market by Route of Administration
9.3.5.2.2 China Benztropine Mesylate Market by Application
9.3.5.3 India Benztropine Mesylate Market
9.3.5.3.1 India Benztropine Mesylate Market by Route of Administration
9.3.5.3.2 India Benztropine Mesylate Market by Application
9.3.5.4 Japan Benztropine Mesylate Market
9.3.5.4.1 Japan Benztropine Mesylate Market by Route of Administration
9.3.5.4.2 Japan Benztropine Mesylate Market by Application
9.3.5.5 South Korea Benztropine Mesylate Market
9.3.5.5.1 South Korea Benztropine Mesylate Market by Route of Administration
9.3.5.5.2 South Korea Benztropine Mesylate Market by Application
9.3.5.6 Rest of Asia-Pacific Benztropine Mesylate Market
9.3.5.6.1 Rest of Asia-Pacific Benztropine Mesylate Market by Route of Administration
9.3.5.6.2 Rest of Asia-Pacific Benztropine Mesylate Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Benztropine Mesylate Market Overview
9.4.2 Middle East and Africa Benztropine Mesylate Market Forecasts and Analysis
9.4.3 Middle East and Africa Benztropine Mesylate Market Forecasts and Analysis - By Route of Administration
9.4.4 Middle East and Africa Benztropine Mesylate Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Benztropine Mesylate Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Benztropine Mesylate Market
9.4.5.1.1 South Africa Benztropine Mesylate Market by Route of Administration
9.4.5.1.2 South Africa Benztropine Mesylate Market by Application
9.4.5.2 Saudi Arabia Benztropine Mesylate Market
9.4.5.2.1 Saudi Arabia Benztropine Mesylate Market by Route of Administration
9.4.5.2.2 Saudi Arabia Benztropine Mesylate Market by Application
9.4.5.3 U.A.E Benztropine Mesylate Market
9.4.5.3.1 U.A.E Benztropine Mesylate Market by Route of Administration
9.4.5.3.2 U.A.E Benztropine Mesylate Market by Application
9.4.5.4 Rest of Middle East and Africa Benztropine Mesylate Market
9.4.5.4.1 Rest of Middle East and Africa Benztropine Mesylate Market by Route of Administration
9.4.5.4.2 Rest of Middle East and Africa Benztropine Mesylate Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Benztropine Mesylate Market Overview
9.5.2 South and Central America Benztropine Mesylate Market Forecasts and Analysis
9.5.3 South and Central America Benztropine Mesylate Market Forecasts and Analysis - By Route of Administration
9.5.4 South and Central America Benztropine Mesylate Market Forecasts and Analysis - By Application
9.5.5 South and Central America Benztropine Mesylate Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Benztropine Mesylate Market
9.5.5.1.1 Brazil Benztropine Mesylate Market by Route of Administration
9.5.5.1.2 Brazil Benztropine Mesylate Market by Application
9.5.5.2 Argentina Benztropine Mesylate Market
9.5.5.2.1 Argentina Benztropine Mesylate Market by Route of Administration
9.5.5.2.2 Argentina Benztropine Mesylate Market by Application
9.5.5.3 Rest of South and Central America Benztropine Mesylate Market
9.5.5.3.1 Rest of South and Central America Benztropine Mesylate Market by Route of Administration
9.5.5.3.2 Rest of South and Central America Benztropine Mesylate Market by Application
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL BENZTROPINE MESYLATE MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. BENZTROPINE MESYLATE MARKET, KEY COMPANY PROFILES
12.1. AKORN
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ZYDUS PHARMACEUTICALS
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. ANI PHARMACEUTICALS
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. PLIVA
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. FRESENIUS KABI
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. HIKMA PHARMACEUTICALS
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. CIPLA
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. NAVINTA
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. ASPEN PHARMACARE
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. HOSPIRA INC.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
12.11. LGM PHARMA
12.11.1. Key Facts
12.11.2. Business Description
12.11.3. Products and Services
12.11.4. Financial Overview
12.11.5. SWOT Analysis
12.11.6. Key Developments
12.12. SG PHARMA
12.12.1. Key Facts
12.12.2. Business Description
12.12.3. Products and Services
12.12.4. Financial Overview
12.12.5. SWOT Analysis
12.12.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. Akorn
2. Zydus Pharmaceuticals
3. ANI Pharmaceuticals
4. PLIVA
5. Fresenius Kabi
6. Hikma Pharmaceuticals
7. Cipla
8. Navinta
9. Aspen Pharmacare
10. Hospira Inc.
11. LGM Pharma
12. SG Pharma
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.